Compound Detail
CHEMBL812
PYRIDOSTIGMINE BROMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL812 |
| Name | PYRIDOSTIGMINE BROMIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | VNYBTNPBYXSMOO-UHFFFAOYSA-M |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1115 |
| Active Moiety | CHEMBL1115 |
2
Targets
10
Activities
1
Assay Types
0
PK Parameters
20
Publications
14
Known Names
9
Indications
1
Mechanisms
Molecular Properties
181.2
MW (Da)
0.57
ALogP
2
HBA
0
HBD
33.4
PSA (Ų)
0.59
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1955 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Acetylcholinesterase inhibitor | INHIBITOR | Acetylcholinesterase | ✓ | ✓ |
Indications
Myasthenia Gravis Heart Failure Hypotension Ileus Parkinson Disease Severe Acute Respiratory Syndrome Spinal Muscular Atrophies of Childhood Hypotension, Orthostatic Glycogen Storage Disease Type II
Drug Warnings
Black Box Warning
General Warning
Activity Summary
IC50 10 meas. best 6.46
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Acetylcholinesterase CHEMBL220 | IC50 | 6.46 | 6.044 | 350.0 | 5 |
| Cholinesterase CHEMBL1914 | IC50 | 6.05 | 6.0125 | 900.0 | 4 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine